A colorimetric method for the measurement of whole-blood glycosylation (WBG), glycosylated haemoglobin in red blood cells (GHb), glycosylated plasma protein (GPP) and dried-blood glycosylation (DBG) is described which is rapid, inexpensive and precise. GHb correlated well with HbA\ measured by cation-exchange chromatography and was also correlated with WBG, DBG and GPP. DBG, which showed good correlation with GHb, could be measured on several drops of blood dried on filter paper treated with glucose oxidase. Filter papers are posted to the laboratory prior to clinic visits, and by having the DBG result available more rational diabetic management is possible. For DBG, the intra-and inter-assay coefficient of variation at three levels is less than 6%. Reference values in non-diabetic children have been calculated and are compared with values obtained in 'good' clinical diabetic control and in 'fair' control. The filter-paper assay DBG method has a high degree of patient acceptance.
Glycosylated haemoglobin was first described in the blood of diabetic patients in 1967 by Rahbar. I It was designated HhAj.; being the third of five minor haemoglobin components eluted from .a Bio-Rex 70 column before the major portion of haemoglobin A o . 2 Further studies have revealed extra sites of glycosylation other than the N-terminal amino groups of valine on the~-chains as found in HbA 1c ' The glycosylation of haemoglobin can now be described as the post-translational non-enzymatic condensation between the aldehyde of glucose and both N-terminal amino groups of a-and -chains and E-amino groups of lysine residues of a-and f3-chains. 3 Glucose is first bound in a reversible Schiff-base (aldimine) linkage; some of this labile glycosylated haemoglobin undergoes an irreversible Amadori rearrangement to a stable ketoamine (amino-1-deoxyfructose) form."
In any individual the level of stable ketoamine is related to the integrated blood glucose level throughout the l20-day life span of the red blood cell." With the introduction in the early seventies of routine cation-exchange assays of Correspondence: D. Kreutzmann.
HbA lc s h it was hoped that diabetic management would be improved by having a parameter that would reflect long-term control. 7 However, it became apparent that the minicolumn had a number of serious problems in practical application; e.g., sensitivity to minor pH changes, temperature fluctuation, minor haernoglobinopathies and sample storage conditions. !l-14 Lactesence resulting from hyperlipaemic samples also gave falsely high results.
The colorimetric method for glycosylated haemoglobin first described by Fluckiger and Winterhalter? appeared to have none of the above-mentioned problems; it had the added advantage of measuring total glycosylation of haemoglobin and it could also be used to measure the glycosylation of other proteins. \1>--22 This method is based on the liberation of the ketoamine-linked glucose as 5-hydroxymethylfurfural (HMF) during acid hydrolysis which reacts characteristically with thiobarbituric acid (TBA) to give a yellow colour at 443 nm. However, it also had some undesirable features for routine usage. These were the need for a large sample volume (2 ml of whole blood), and a 5-hour hydrolysis which lacked precision if the laborious adjustment of haemoglobin content in the samples was not made. 2 J-28 Since most of the children seen in our Diabetic Clinic at the Royal Alexandra Hospital for Children were already using home blood glucose monitoring and some lived in remote areas of the state of New South Wales, we wondered whether it would be possible to measure glycosylated haemoglobin in dried blood-spots obtained from a finger-prick and posted to the laboratory.
In this paper we describe a colorimetric method for the measurement of whole blood glycosylation (WBG), glycosylated haemoglobin in red blood cells (GHb), glycosylated plasma protein (GPP) and dried blood glycosylation (DBG) which is rapid, inexpensive and precise.
Materials and methods

SAMPLE COLLECTION
'Non-diabetic' samples were obtained from children with no evidence of endocrine or haematological disease who were having blood drawn for other medical reasons. Samples from children with insulin-dependent diabetes were obtained as part of blood tests performed routinely in our metabolic ward. None were in the remission phase. The children's ages ranged from 4 months to 15 years.
Heparinised blood stored at 4°C was centrifuged within 6--12 hours after collection, separated, and the RBCs washed once with four volumes of saline. The packed red cells were reconstituted with saline to the original whole blood volume and stored at 4°C until assayed.
Filter papers (grade 2992, Schleicher & Scheull, FRG) were prepared by dipping them into a solution of glucose oxidase and allowing them to air dry. The children were asked to fill two circles with blood (50 ilL per circle) from a finger-prick, to let it air dry, label it with their name, the date, the blood glucose level (measured on their home blood-glucose monitor), and post it to the laboratory as soon as possible.
APPARATUS
For the assay we used screw-capped glass tubes with Teflon-lined caps (Kimax 13X 100 mm culture tube 450066-A, Kimble, Ill., USA). The centrifuge was an IEC Centra 7R (Damon, Mass, USA). The spectrophotometer was an SP6-550 Pye-Unicam (Pye-Unicam Ltd, Cam-bridge, UK). The boiling water-bath was a Labec C663 (Laboratory Equipment, Sydney, Australia).
REAGENTS
Analytical reagent-grade trichloracetic acid and orthophosphoric acid were obtained from Ajax Chemicals, Sydney. Thiobarbituric acid and 5-hydroxymethylfurfural (HMF) were purchased from Merck, Darmstadt, FRG. For the glucose oxidase solution we used Glucose Reagent as supplied by Beckman Instruments, Fullerton, Calif. 92634, USA. The active ingredient is glucose oxidase (A. niger) 150 IU/mL.
PROCEDURES
Glucose, protein and haemoglobin determinations
Plasma glucose was measured by a Glucose Analyser (Beckmanj.j" Plasma protein was measured by the Biuret method on a Microlyser (Technicon). Haemoglobin was determined by using Drabkins reagent and recording the absorbance at 540 nrn.
Hb A], Washed reconstituted blood was chromatographed on commercially available cationexchange minicolumns (Isolab), Assays were performed in duplicate at 22±2°C. Buffer pH was checked and columns equilibrated with this buffer prior to use. Elution of a sample from any column was continued until complete elution of the haemoglobin occurred. Values obtained were adjusted according to the manufacturer's temperature correction chart. 311 Samples from children less than 1 year of age were not used because of high levels of haemoglobin F (HbF).
Colorimetric method for WBG, GHb, GPP and DBG. For the colorimetric assay of WBG, GHb and Gpp,31 50 ul, of whole blood, or of washed reconstituted blood, or 100 ul, of plasma, was placed in a screw-capped glass tube (Kimax 13x 100 mm) with 1 mL of distilled water. For DBG measurement, filter paper spots were cut out and placed in same type of tube. The blood was eluted with 1 mL of distilled water for 1 hour, and then the filter paper was removed from the haemolysate (overnight elution was used for very' old spots). After removing 50 ul, of the haemolysate for haemoglobin estimation, 0·5 mL of 400 gIL trichloracetic acid solution (TCA) was added to the remainder and the solution centrifuged at 1500 g for 10 min. The supernatant was decanted and discarded. Following the addition of 1 mL of 2·5 mol/L phosphoric acid (H 3 P0 4 ) to the precipitate, the tubes were sealed tightly with Teflon-lined caps and placed in a boiling water bath for 1 hour. After cooling to room temperature, a further 0·5 mL of TCA was added and the tubes centrifuged at 1500 g for 10 min. The supernatants were decanted into lOx75 mm glass tubes. A solution consisting of 1 mL of H 3 P0 4 and 0·5 mL of TCA was used for the reagent blank and standards (5-50 nmol/tube of HMF). Then 0·5 mL of 50 mmol/L thiobarbituric acid solution (TBA) was added to all tubes, including the reagent blank, which were incubated at 40°C for 30 min. The tubes were allowed to cool to room temperature for 15 min, then centrifuged at 1500 g for 5 min. The absorbance was read at 443 nm against the reagent blank.
The absorbance of each standard was plotted against its corresponding HMF level. From this graph the amount of HMF produced by each sample (nmol HMF per 50 ilL or 100 ilL sample) was read directly. The haemoglobin concentration (mg Hb per 50 ul, sample) and the protein concentration (mg protein per 100 ul, sample) were also determined.
The final parameters were then calculated as follows: GPP* nmol HMF/l00 ilL mg protein/lOU ilL x 10 3 pmol HMF/mg protein Low, medium and high quality-control haemolysates were prepared from red blood cells of normal and diabetic children. These were stable when stored at -20°C for at least 2 years. Fig. 1 demonstrates the linearity of thiobarbituric colour development over the range 5-50 nmol HMF/tube under assay conditions. The reagent blank read against distilled water gave repeated absorbance readings of 0·015.
Results
COLORIMETRIC MEASUREMENT OF GLYCOSYLATION
The mean amount of HMF produced in five non-diabetic and seven diabetic samples with increasing hydrolysis time is shown in Fig. 2 . Because GHb values for these children ranged from 980 to 3420 pmol HMF/mg Hb the mean amount of HMF produced at 1 hour for all samples was set at 100%. Sample blank values (consisting of the hydrolysed sample to which no TBA was added) gave repeated absorbance readings of 0·006 for 1 hour and doubled each hour. These have been subtracted from final absorbance readings in Fig. 2 . We found much higher blank values when 5 mol/L phosphoric acid or 2·5 mol/L sulphuric acid were used and finally selected 2·5 mol/L phosphoric acid for 1 hour at 100°C for our hydrolysis procedure. As the sample blank under these conditions was minimal we chose the quite significant reagent blank to be subtracted from all standards and samples in the final assay procedure.
The absorbance readings from the colorimetric assay performed on varying haemoglobin quantities of the same haemolysate ranging from 2 to 25 mg showed a linear relationship with zero intercept (Fig. 3) . This relationship meant that the specific release of HMF/mg Hb was the same at each level of Hb. This allowed us to measure accurately samples of varying haemoglobin levels. Intra-assay and inter-assay precision of GHb in low, medium and high quality controls are listed in Table 1 . Table 2 shows the reference values (me~n±SD) of non-diabetic children for glycosylated protein (WGB, GHb, GPP and DBG).
Glycosylated haemoglobin (GHb) levels measured in diabetic and non-diabetic samples by the colorimetric assay correlated well with results from a rigidly controlled ion-exchange method for HbA] (Fig. 4) . Correlations of WBG, DBG and GPP with GHb are presented in Table 3 centration (Fig. 5 ). This resulted in a linear relationship y= -98+ 115x (r=0·98, n=6) . As a further experiment, increasing amounts of 10% dextrose were added to blood taken from a non-diabetic subject A.B. Again a linear relationship was demonstrated when the discrepancy between DBG from untreated filter paper and WBG was plotted against blood glucose ( Fig. 5 ), y=34+68x (,=0,99, n= 10). We overcome this problem of the rapid in-situ glycosylation during drying of blood by treating the filter papers with glucose oxidase prior to spotting the blood samples ( Fig. 5) .
We found filter papers treated with glucose oxidase and stored at room temperature remained active for at least 8 months after impregnation and we were able to measure DBG in blood-spots stored at room temperature for 3 months (recovery 89±4'7'0, n=20).
Intra-and inter-assay precision of DBG in low, medium and high quality-control samples gave coefficients of variation which were all less than 6%. Using our clinical judgement we have found that diabetics with 'good' clinical control have DBG less than 1600 pmol HMF/mg Hb and with 'fair' clinical control 1600-2000 pmol HMF/mg Hb. Initial experiments showed a parallel relationship between DBG from untreated filter paper and WBG in non-diabetic children but a non-parallel relationship in diabetic children, where unexpectedly high DBG levels were found. Suspecting this was due to elevated glucose levels in the diabetic sample, we compared DBG from untreated filter paper and WBG levels in a diabetic subject D.L. during one 24 h period and plotted the difference (DBG-WBG) against the blood glucose con- 
Discussion
With this method it has been possible to measure glycosylated haemoglobin in diabetic and non-diabetic children using SO I-lL of washed reconstituted blood or several drops of dried blood obtained by finger-prick. In addition it was also possible to measure wholeblood glycosylation and glycosylated plasma protein (GPP) from fresh blood.
Keeney and Bassette 16 originally used 0·15 mol/L oxalic acid for hydrolysis because it maximally released hydroxymethylfurfural from the early intermediates of the browning reaction in milk without causing significant primary degradation of lactose. Fluckiger and Winterhalter adapted this method for glycosylated haemoglobin measurement. 15 Gabbay et at. 25 improved sensitivity by using 0·5 mol/L oxalic acid for 5 hours and Pecararo et al. 26 achieved better precision by correcting for the 'non-stoichiornetry'i'" These studies led us to believe that the release of HMF from ketoamine-linked glucose would be accelerated by increasing the acid concentration. With' higher concentration of acid there is the danger that primary degradation of glucose to HMF in the sample would interfere. We therefore introduced a preliminary separation of protein from glucose by TCA precipitation of total protein.
Because of solubility problems with oxalic acid solutions of concentration greater than 1 rnol/L we decided to use phosphoric acid, a mineral acid of similar strength. Hydrolysis using 2·5 molfL phosphoric acid was found to give maximal release of HMF by 1 hour without significant blank problems and provided us with a rapid, inexpensive and precise assay. The assay requires equipment that is readily available in most laboratories and could be performed in under 3 hours. The method lends itself to large batches allowing 80 samples to be completed in a working day.
Sample blanks which consisted of hydrolysed sample to which no TBA was added, gave repeated absorbance readings (0·006) that were a third of sample blanks (0'018) found by a previous hydrolysis method.V This low level of non-specific absorbance probably explains why we were able to achieve good precision even at low levels of haemoglobin ( Fig. 3) . Other methods/": 28 achieved this degree of precision only by adjusting or correcting for the haemoglobin level. Our reference range in nondiabetics was 20% higher than that reported by Standefer et at. 32 who calculated a consistent 20% loss of HMF during hydrolysis. This probably suggests that our method causes less destruction of HMF during hydrolysis.
The filter paper technique has proven reliable with samples sent by post from as far as New Zealand and Italy. The glucose oxidase on the filter paper remained active for at least 8 months after impregnation when stored at room temperature. We tested the stability of glycosylated haemoglobin on glucose-oxidase treated filter papers and found accurate and reliable results could be obtained in 3-month-old samples stored at room temperature. The major limiting factor was poor recovery of haemoglobin from the paper. However, providing there was at least 2 mg of haemoglobin in the eluate glycosylated haemoglobin could be measured.
The demonstration of glucose binding to haemoglobin during the drying of blood may explain the alteration of the electrophoretic mobility of haemoglobin in blood stains.P Similarly, it would explain the increased glycosylation found in blood spotted on filter paper.P"
As well as having good correlation with HbA 1 , GHb showed excellent correlation with DBG. This, together with the observation that there is minimal contribution from plasma protein ( Table 3 ) led us to the routine use of DBG for all our diabetic patients. Not only does DBG have equally good assay precision but also has several major advantages over previous techniques. Firstly, it avoids venepuncture and so has a high degree of patient acceptance. Secondly, the sample may be collected at home and posted 2 weeks prior to the clinical visit so that the result is available at that consultation. Thirdly, DBG would be an excellent tool for epidemiological purposes if a survey for diabetes is contemplated.
In conclusion, we have presented the details of a rapid, inexpensive, reliable colorimetric method for the estimation of glycosylated protein in whole blood, red blood cells, plasma or dried blood on filter paper. This last technique has logistic advantages which should further improve monitoring of therapy in diabetic patients.
